Prima Wiyata Health
Vol 7 No 1 (2026): Prima Wiyata Health: Januari 2026

FAMILY SUPPORT AND MEDICATION ADHERENCE AMONG PATIENTS WITH SCHIZOPHRENIA IN PRIMARY HEALTHCARE

Nurkhalisah (Unknown)
Masnina, Rusni (Unknown)
Asthiningsih, Ni Wayan Wiwin (Unknown)



Article Info

Publish Date
24 Jan 2026

Abstract

Background: Schizophrenia is a chronic mental disorder requiring long-term pharmacological treatment. Medication non-adherence remains a major challenge and contributes to relapse and rehospitalization. In primary healthcare settings, family support is considered a key psychosocial factor influencing medication adherence. Objectives: This study aimed to examine the association between family support and medication adherence among outpatients with schizophrenia in a primary healthcare setting. Methods: An analytical cross-sectional study was conducted at Puskesmas Loa Bakung Samarinda, Indonesia. A total of 40 schizophrenia outpatients were recruited using total sampling. Family support was measured using the Duke-UNC Functional Social Support Questionnaire, while medication adherence was assessed with the Morisky Medication Adherence Scale-8 (MMAS-8). Data were analyzed using univariate analysis and Chi-square or Fisher’s exact test, with odds ratio (OR) estimation at a significance level of p < 0.05. Results: Of the respondents, 52.5% reported sufficient to high family support, while 47.5% reported low support. Medication adherence was categorized as low in 57.5% of patients, moderate in 17.5%, and high in 25.0%. A significant association was found between family support and medication adherence (p = 0.022). Patients with low family support had a sixfold higher risk of non-adherence compared to those with sufficient or high family support (OR = 6.094). Conclusion: Family support is significantly associated with medication adherence among patients with schizophrenia in primary healthcare. Strengthening family involvement in community-based mental health services is essential to improve adherence and reduce the risk of relapse.

Copyrights © 2026